Aptinyx Inc (APTX)

Sector:
HEALTH CARE
Industry:
BIOTECHNOLOGY & LIFE SCIENCES
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Dr. Norbert G. Riedel
Employees:
63
1801 MAPLE AVENUE, SUITE 4300, EVANSTON, IL 60201
847-871-0377

Aptinyx Inc., a clinical-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of novel, proprietary, and synthetic small molecules for the treatment of brain and nervous system disorders.

Data derived from most recent annual or quarterly report
Market Cap 193.667 Million Shares Outstanding67.716 Million Avg 30-day Volume 139.079 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.51
Price to Revenue117.137 Debt to Equity0.0 EBITDA-48.844 Million
Price to Book Value1.3732 Operating Margin-2859.0492999999997 Enterprise Value57.532 Million
Current Ratio39.301 EPS Growth0.419 Quick Ratio37.857
1 Yr BETA 1.312 52-week High/Low 4.73 / 2.06 Profit Margin-2839.0034
Operating Cash Flow Growth19.6174 Altman Z-Score29.101 Free Cash Flow to Firm -35.576 Million
View SEC Filings from APTX instead.

View recent insider trading info

Funds Holding APTX (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding APTX BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

162.7 Thousand total shares from 3 transactions

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

MILLER JOAN W.

17,700 2022-01-13 4

RIEDEL NORBERT G CEO

1,355,873 2021-12-06 5

KIDD ANDREW PRESIDENT & COO

800,000 2021-12-02 3

KHANNA ASHISH CFO AND CBO

421,840 2021-12-02 4

HOMBACH ROBERT J.

229,100 2021-11-11 3

O'NEILL GILMORE NEIL

80,000 2021-10-19 2

ENRIGHT PATRICK G

40,000 2021-05-27 1

GOULD TERRY P

40,000 2021-05-27 1

KOPPEL ADAM

  • Director
  • 10% Owner
40,000 2021-05-27 1

GOSEBRUCH HENRY O

40,000 2021-05-27 1

SHERMAN RACHEL E.

40,000 2021-05-27 1

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

SCHWARTZ JEFFREY LAWRENCE

KOPPEL ADAM

  • Director
  • 10% Owner
8,891,758 2020-10-26 0

ADAMS STREET PARTNERS LLC

  • 10% Owner
0 2020-09-30 0

GANTZ WILBUR H

  • Director
0 2020-03-31 0

TOPPER JAMES N

  • Director
3,195,055 2020-03-31 0

BAIN CAPITAL LIFE SCIENCES INVESTORS, LLC

BAIN CAPITAL LIFE SCIENCES PARTNERS, LP

BAIN CAPITAL LIFE SCIENCES FUND, L.P.

BCIP LIFE SCIENCES ASSOCIATES, LP

SCHWARTZ JEFFREY LAWRENCE

  • 10% Owner
5,558,425 2020-01-14 0

MOSKAL JOSEPH R. CHIEF SCIENTIFIC OFFICER

  • Officer
0 2019-05-16 0

RATCLIFFE LIAM

  • Director
0 2019-03-29 0

MADSEN TORSTEN M. CHIEF MEDICAL OFFICER

  • Officer
232,600 2019-01-28 0

HOUCK DAVID CHIEF DEVELOPMENT OFFICER

  • Officer
0 2019-01-04 0

FRAZIER LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.P.

FHM LIFE SCIENCES VIII, L.L.C.

HERON PATRICK J

  • 10% Owner
No longer subject to file 2018-06-25 0

LONGITUDE CAPITAL PARTNERS II, LLC

TAMMENOMS BAKKER JULIET

LONGITUDE VENTURE PARTNERS II, L.P.

  • 10% Owner
No longer subject to file 2018-06-25 0

NEW LEAF VENTURE MANAGEMENT III, L.L.C.

NEW LEAF VENTURE ASSOCIATES III, L.P.

NEW LEAF VENTURES III, L.P.

NEW LEAF BIOPHARMA OPPORTUNITIES I, L.P.

NEW LEAF BPO ASSOCIATES I, L.P.

  • 10% Owner
No longer subject to file 2018-06-25 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

MILLER JOAN W.

2022-01-18 16:19:12 -0500 2022-01-13 P 17,700 $2.83 a 17,700 direct 6.4151 6.4151 2 0.0 1

RIEDEL NORBERT G CEO by riedel 2020 irrevocable trust

2021-12-08 16:16:23 -0500 2021-12-06 P 100,000 $2.23 a 100,000 indirect -1.4388 -7.554 6.4748 3 -7.554 6

KHANNA ASHISH CFO AND CBO

2021-12-06 16:16:10 -0500 2021-12-02 P 45,000 $2.26 a 420,040 direct 11.4035 19.7368 23.6842 31.5789 13 0.0 1

RIEDEL NORBERT G CEO

2021-12-07 16:16:13 -0500 2021-12-02 A 475,000 a 475,000 direct

KIDD ANDREW PRESIDENT & COO

2021-12-07 16:17:03 -0500 2021-12-02 A 800,000 a 800,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
APTINYX INC APTX 2022-01-21 22:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 21:45:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 21:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 20:45:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 20:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 19:45:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 19:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 18:45:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 18:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 17:45:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 17:15:03 UTC -1.888 1.958 900000
APTINYX INC APTX 2022-01-21 16:45:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 16:15:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 15:45:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 15:15:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 14:45:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 14:15:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 13:45:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 13:15:03 UTC -1.7656 1.8356 900000
APTINYX INC APTX 2022-01-21 12:45:03 UTC -1.7656 1.8356 900000

Current Active Short Positions

Get more info on our International short position coverage here

Holder Issuer Net Short Position Position Date Origin

Short Position History (International Only)

Holder Net Short Position Position Date Origin
Squarepoint Ops LLC Aptinyx Inc 0.56% 2019-11-08 UK
Squarepoint Ops LLC Aptinyx Inc 0.75% 2019-10-04 UK
Squarepoint Ops LLC Aptinyx Inc 0.69% 2019-10-16 UK
Squarepoint Ops LLC Aptinyx Inc 0.92% 2019-08-15 UK
Squarepoint Ops LLC Aptinyx Inc 0.89% 2019-08-29 UK

Elevate your investments